Loading...
Loading...
QTRX| Name | Value |
|---|---|
| Revenues | 31.5M |
| Cost of Revenue | 18.5M |
| Gross Profit | 13.1M |
| Operating Expense | 31.2M |
| Operating I/L | -18.1M |
| Other Income/Expense | -0.6M |
| Interest Income | 4.3M |
| Pretax | -12.3M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | -12.4M |
Quanterix Corporation develops and markets digital immunoassay platforms for life sciences research and diagnostics globally. Its products include sensitive automated multiplex protein detection platforms, instruments for Simoa detection technology, and planar array technology for multiplex chemiluminescent immunoassays. The company also offers assay kits, consumables, and contract research services in neurology, oncology, cardiology, infectious diseases, and inflammation. It primarily sells to laboratories associated with academic and governmental research institutions, pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents.
